Clinical Trial Update: Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the combination of retinoic acid, arsenic trioxide, and chemotherapy for newly diagnosed acute promyelocytic leukemia (APL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Retinoic acid (all-trans retinoic acid)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Promyelocytic Leukemia | Phase 4 | Status: UNKNOWN